Concepedia

Heinrich Urwyler

HU

Statistics

Publications

12

Citations

1.9K

H-Index

12

Active since

1994

Affiliations

Roche (Switzerland)(Current)

Basilea Pharmaceutica (Switzerland)

Swiss Tropical and Public Health Institute

University of Nebraska Medical Center

Monash University

Heinrich Urwyler is an author at Roche (Switzerland) specializing in pharmacology, antimalarial drug development, and drug discovery.

Publications per year

1994–2017

12

Publications

12

Identification of an antimalarial synthetic trioxolane drug development candidate

Jonathan L. Vennerstrom, Sarah Arbe‐Barnes, Reto Brun et al. · Nature · 2004 · 617 citations

, , +10

Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria

Susan A. Charman, Sarah Arbe‐Barnes, Ian Bathurst et al. · Proceedings of the National Academy of Sciences · 2011 · 376 citations · Full text

, , +14

4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum

Robert G. Ridley, W. Hofheinz, Hugues Matile et al. · Antimicrobial Agents and Chemotherapy · 1996 · 221 citations · Full text

, , +17

Fluoroquinolone antibacterials enhance UVA-induced skin tumors

G. Klecak, Frederick Urbach, Heinrich Urwyler · Journal of Photochemistry and Photobiology B Biology · 1997 · 204 citations

, , +11

Spiro and Dispiro-1,2,4-trioxolanes as Antimalarial Peroxides:  Charting a Workable Structure−Activity Relationship Using Simple Prototypes

Yuxiang Dong, Jacques Chollet, Hugues Matile et al. · Journal of Medicinal Chemistry · 2005 · 117 citations

, , +17

1–5 of 12